A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia - Concepedia

Concepedia

Publication | Open Access

A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia

DOI Full Paper Access

221

Citations

22

References

2014

Year

Samir S. Awad, Alejandro Rodríguez, Yin-Ching Chuang, Z Marjanek, A. J. Pareigis, Gilmar Reis, Thomas Scheeren, Xin Zhou, Mikael Saulay, Marc Engelhardt

Clinical Infectious Diseases

Abstract

Ceftobiprole is a safe and effective bactericidal antibiotic for the empiric treatment of HAP (excluding VAP). Further investigations are needed before recommending the use of ceftobiprole in VAP patients. Clinical Trials Registration. NCT00210964, NCT00229008.

References

	Year	Citations

Page 1